815 related articles for article (PubMed ID: 29019612)
1. Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.
Castaño A; Narotsky DL; Hamid N; Khalique OK; Morgenstern R; DeLuca A; Rubin J; Chiuzan C; Nazif T; Vahl T; George I; Kodali S; Leon MB; Hahn R; Bokhari S; Maurer MS
Eur Heart J; 2017 Oct; 38(38):2879-2887. PubMed ID: 29019612
[TBL] [Abstract][Full Text] [Related]
2. Concomitant Transthyretin Amyloidosis and Severe Aortic Stenosis in Elderly Indian Population: A Pilot Study.
Singal AK; Bansal R; Singh A; Dorbala S; Sharma G; Gupta K; Saxena A; Bhargava B; Karthikeyan G; Ramakrishnan S; Bisoi AK; Hote MP; Rajashekar P; Chowdhury UK; Devagourou V; Patel C; Ray R; Arawa SK; Mishra S
JACC CardioOncol; 2021 Oct; 3(4):565-576. PubMed ID: 34746852
[TBL] [Abstract][Full Text] [Related]
3. Amyloid Transthyretin Cardiomyopathy in Elderly Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation.
Dobner S; Pilgrim T; Hagemeyer D; Heg D; Lanz J; Reusser N; Gräni C; Afshar-Oromieh A; Rominger A; Langhammer B; Reineke D; Windecker S; Stortecky S
J Am Heart Assoc; 2023 Aug; 12(16):e030271. PubMed ID: 37581394
[TBL] [Abstract][Full Text] [Related]
4. Utility of left atrial and ventricular strain for diagnosis of transthyretin amyloid cardiomyopathy in aortic stenosis.
Oike F; Usuku H; Yamamoto E; Marume K; Takashio S; Ishii M; Tabata N; Fujisue K; Yamanaga K; Sueta D; Hanatani S; Arima Y; Araki S; Oda S; Kawano H; Soejima H; Matsushita K; Ueda M; Fukui T; Tsujita K
ESC Heart Fail; 2022 Jun; 9(3):1976-1986. PubMed ID: 35338611
[TBL] [Abstract][Full Text] [Related]
5. Routine 4D Cardiac CT to Identify Concomitant Transthyretin Amyloid Cardiomyopathy in Older Adults with Severe Aortic Stenosis.
Bernhard B; Leib Z; Dobner S; Demirel C; Caobelli F; Rominger A; Schütze J; Grogg H; Alwan L; Spano G; Boscolo Berto M; Lanz J; Pilgrim T; Windecker S; Stortecky S; Gräni C
Radiology; 2023 Dec; 309(3):e230425. PubMed ID: 38085082
[TBL] [Abstract][Full Text] [Related]
6. Reverse Remodeling Following Valve Replacement in Coexisting Aortic Stenosis and Transthyretin Cardiac Amyloidosis.
Nitsche C; Koschutnik M; Donà C; Radun R; Mascherbauer K; Kammerlander A; Heitzinger G; Dannenberg V; Spinka G; Halavina K; Winter MP; Calabretta R; Hacker M; Agis H; Rosenhek R; Bartko P; Hengstenberg C; Treibel T; Mascherbauer J; Goliasch G
Circ Cardiovasc Imaging; 2022 Jul; 15(7):e014115. PubMed ID: 35861981
[TBL] [Abstract][Full Text] [Related]
7. Optimal Echocardiographic Parameters to Improve the Diagnostic Yield of Tc-99m-Bone Avid Tracer Cardiac Scintigraphy for Transthyretin Cardiac Amyloidosis.
Cuddy SA; Datar Y; Ovsak G; Saith S; Murphy SP; Bay CP; Haddad M; Lilleness B; Muralidhar V; Pipilas A; Vuong J; Guardino E; Maurer MS; Ruberg FL; Falk RH; Dorbala S
Circ Cardiovasc Imaging; 2022 Nov; 15(11):e014645. PubMed ID: 36378779
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of ATTR-CA and high-risk features to guide testing in patients referred for TAVR.
Abadie B; Ali AH; Martyn T; Higgins A; Krishnaswamy A; Reed G; Puri R; Yun J; Cremer P; Hanna M; Tang WHW; Kapadia S; Jaber W
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3910-3916. PubMed ID: 37606857
[TBL] [Abstract][Full Text] [Related]
9. Transthyretin cardiac amyloidosis in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: experience of a single center.
Gallone G; Bongiovanni C; Bruno F; Landra F; Andreis A; Fava A; Scudeler L; DE Filippo O; Califaretti E; Cioffi M; Pidello S; Vairo A; Raineri C; Frea S; Giorgi M; Alunni G; Casoni R; Salizzoni S; Conrotto F; D'Ascenzo F; Rinaldi M; DE Ferrari GM
Minerva Cardiol Angiol; 2024 Feb; 72(1):87-94. PubMed ID: 37405712
[TBL] [Abstract][Full Text] [Related]
10. In the midst of a dangerous intersection with unclear therapeutic strategies: a challenging case of severe aortic stenosis.
Gallone G; Landra F; D'Ascenzo F; Conrotto F; Casoni R; Bruno F; Omedè P; Alunni G; Andreis A; Vairo A; Giorgi M; Fava A; De Ferrari GM
BMC Cardiovasc Disord; 2020 Jun; 20(1):261. PubMed ID: 32487051
[TBL] [Abstract][Full Text] [Related]
11. Unveiling outcomes in coexisting severe aortic stenosis and transthyretin cardiac amyloidosis.
Rosenblum H; Masri A; Narotsky DL; Goldsmith J; Hamid N; Hahn RT; Kodali S; Vahl T; Nazif T; Khalique OK; Bokhari S; Soman P; Cavalcante JL; Maurer MS; Castaño A
Eur J Heart Fail; 2021 Feb; 23(2):250-258. PubMed ID: 32729170
[TBL] [Abstract][Full Text] [Related]
12. Transthyretin cardiac amyloidosis in patients after TAVR: clinical and echocardiographic findings and long term survival.
Shimoni S; Zikri M; Haberman D; Livschitz S; Tshori S; Fabricant Y; Meledin V; Gandelman G; Goland S; George J
ESC Heart Fail; 2021 Dec; 8(6):4549-4561. PubMed ID: 34704399
[TBL] [Abstract][Full Text] [Related]
13. Transthyretin Cardiac Amyloidosis as Diagnosed by 99mTc-PYP Scanning in Patients with Acute Heart Failure and Preserved Ejection Fraction.
Lo Presti S; Horvath SA; Mihos CG; Rajadhyaksha C; McCloskey V; Santana O
Crit Pathw Cardiol; 2019 Dec; 18(4):195-199. PubMed ID: 31725511
[TBL] [Abstract][Full Text] [Related]
14. Echocardiographic score for the screening of cardiac amyloidosis with positive 99m technetium pyrophosphate scintigraphy result.
Nagai T; Horinouchi H; Hashimoto K; Ichiji T; Yoshioka K; Hashimoto J; Ikari Y
Echocardiography; 2023 Jul; 40(7):634-641. PubMed ID: 37243310
[TBL] [Abstract][Full Text] [Related]
15. Towards a Diagnosis of Cardiac Amyloidosis: Single Center Experience with
Saleem M; Sadat B; Van Harn M; Ananthasubramaniam K
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837580
[No Abstract] [Full Text] [Related]
16. Association Between Atrial Uptake on Cardiac Scintigraphy With Technetium-99m-Pyrophosphate Labeled Bone-Seeking Tracers and Atrial Fibrillation.
Hussain M; Krywanczyk A; Donnellan E; Martyn T; Hassan OA; Alkharabsheh S; Watson C; Tang WH; Kwon D; Cremer P; Cheng F; Kanj M; Griffin B; Tan C; Rodriguez ER; Hanna M; Jaber W; Collier P
Circ Cardiovasc Imaging; 2022 May; 15(5):e013829. PubMed ID: 35580157
[TBL] [Abstract][Full Text] [Related]
17.
Tahara N; Lairez O; Endo J; Okada A; Ueda M; Ishii T; Kitano Y; Lee HE; Russo E; Kubo T
ESC Heart Fail; 2022 Feb; 9(1):251-262. PubMed ID: 34841715
[TBL] [Abstract][Full Text] [Related]
18. Impact of low flow on the outcome of high-risk patients undergoing transcatheter aortic valve replacement.
Le Ven F; Freeman M; Webb J; Clavel MA; Wheeler M; Dumont É; Thompson C; De Larochellière R; Moss R; Doyle D; Ribeiro HB; Urena M; Nombela-Franco L; Rodés-Cabau J; Pibarot P
J Am Coll Cardiol; 2013 Aug; 62(9):782-8. PubMed ID: 23770162
[TBL] [Abstract][Full Text] [Related]
19. Estimating cancer risk from
Einstein AJ; Shuryak I; Castaño A; Mintz A; Maurer MS; Bokhari S
J Nucl Cardiol; 2020 Feb; 27(1):215-224. PubMed ID: 29850972
[TBL] [Abstract][Full Text] [Related]
20. Diagnosing Transthyretin Cardiac Amyloidosis by Technetium Tc 99m Pyrophosphate: A Test in Evolution.
Poterucha TJ; Elias P; Bokhari S; Einstein AJ; DeLuca A; Kinkhabwala M; Johnson LL; Flaherty KR; Saith SE; Griffin JM; Perotte A; Maurer MS
JACC Cardiovasc Imaging; 2021 Jun; 14(6):1221-1231. PubMed ID: 33221204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
